1 NO. NCH 024/2562 July 11, 2019 Subject : Notice of setting up a new subsidiary under joint venture agreement to cover intermediate care and wellness business Attn. : Director and Manager The Stock
ที่ NCH 23/2549 1 ท่ี NCH 024/2562 วนัที่ 11 กรกฎาคม 2562 เร่ือง แจ้งการร่วมทนุจดัตัง้บริษทัยอ่ยแหง่ใหม ่เพื่อรองรับธุรกจิ Intermediate care และ Wellness เรียน กรรมการ และผู้จดัการ ตลาดหลกัทรัพย์แหง่
the main businesses, the business restructuring of MK Group since 2016 has helped to ease the impact of the economic slowdown. In addition, the Company has planned to launch the wellness business at the
normalization of the Federal Reserve’s balance sheet, the impact of which will be more evident this year, will likely contribute to occasional volatility in capital flows, prompting businesses to manage their
decreased in sales. MK Group was preparing to launch the new business which was Wellness business. The Company incurred pre-opening expenses. MK planned to launched the Wellness business during the fourth
. • Operating Profit: rose by 104.10% YoY • EBITDA: it was made evident that the corporate and business strategy restructuring, efficient cost management together with business reorganization by emphasizing in
statistically significant with a negative sign. Results : A logistic regression model 2 It is evident that when clients move to the Big 4, they pay higher audit fees, especially in 2020. Clients are more likely
% MB % MB % 1. Wellness and Anti-aging 128.58 40.58% 162.70 43.82% 34.12 26.54% 2. Aesthetic Innovation 96.00 30.30% 67.17 18.09% (28.83) (30.03%) 3. Companion Animal Health 80.78 25.50% 132.19 35.60
-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 1st Quarter 2020 1st Quarter 2019 Change MB % MB % MB % 1. Wellness & Anti-Aging 47.77 49.18 31.87 37.52 15.90 49.90% 2. Aesthetic
increased in revenues from sales of medicated pet shampoo, pet foods products, livestock animal products, and revenues from sales of wellness & anti-aging products and aesthetic innovations products. 2. Cost